Abstract

ObjectivesOur understanding of brain fog, or dyscognition, among youth with juvenile fibromyalgia syndrome is limited. We aimed to determine the prevalence of subjective (self-reported) and objective dyscognition, as well as factors associated with subjective dyscognition in juvenile fibromyalgia syndrome.MethodsA cross-sectional cohort study of patients (n = 31) 12-17 years old diagnosed with primary juvenile fibromyalgia syndrome and one of their parents from 2017 to 2019. Subjects completed a series of survey measures and patients completed a brief neurocognitive battery. Subjective dyscognition was determined based on scores on the Pediatric Quality of Life Inventory (PedsQL) Cognitive Functioning Scale and Behavior Rating Inventory of Executive Function (BRIEF-2) global executive composite (GEC). Objective dyscognition was defined as impairment of more than two standard deviations in any of the neurocognitive domains. We used Fisher's exact test or Wilcoxon rank-sum test, as appropriate, to compare clinical patients based on the presence of dyscognition. Multivariable logistic regression modeling was performed to determine factors associated with subjective dyscognition.ResultsOf the 31 subjects, 65% reported subjective dyscognition and 39% had objective dyscognition, primarily in the domains of psychomotor speed (23%), executive function (23%), and attention (3%). Subjective dyscognition was not indicative of objective dyscognition. Subjective dyscognition was independently associated with functional disability (OR: 1.19 [95% CI: 1.02-1.40]) and anxiety (OR: 1.12 [95% CI: 1.02-1.24]).DiscussionAdolescents with fibromyalgia predominantly experience subjective dyscognition but more than 1/3 also experience objective dyscognition. Future research should explore the impact of interdisciplinary rehabilitation programs on the treatment of dyscognition in youth with JFMS.

Highlights

  • 50% of adults with fibromyalgia report cognitive impairment including difficulty in ability to attend, concentrate, remember, use language, multitask, and organize information [1, 2]

  • Three subjects were excluded from analyses due to poor performance validity on the Memory Validity Profile (MVP)/Medical Symptom Validity Test (MVST), resulting in 31 evaluable subjects

  • Patient-proxy agreement on mental health and neuropsychological symptoms was good to excellent (ICC ranging from 0.60 [95% CI: 0.19-0.80] to 0.86 [95% CI: 0.710.93]) and we focused on the patient self-report for the remaining analyses

Read more

Summary

Introduction

50% of adults with fibromyalgia report cognitive impairment (referred to as brain fog or “fibro fog”) including difficulty in ability to attend, concentrate, remember, use language, multitask, and organize information [1, 2]. This co-morbid neuropsychological symptom pattern in adults with fibromyalgia has been termed cognitive dysfunction or dyscognition, which includes loss of mental clarity and problems with attention and memory [3,4,5,6]. These factors should be formally assessed when evaluating an individual’s cognitive functioning

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call